Cart
sales@molnova.com
TERT-IN-1
CAS No. 257891-65-9
TERT-IN-1( —— )
Catalog No. M37513 CAS No. 257891-65-9
TERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 306 | In Stock |
|
| 10MG | 446 | In Stock |
|
| 25MG | 720 | In Stock |
|
| 50MG | 918 | In Stock |
|
| 100MG | 1293 | In Stock |
|
| 200MG | 1748 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTERT-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
-
DescriptionTERT-IN-1 has anti-HIV activity and can be used to study HIV infection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number257891-65-9
-
Formula Weight321.87
-
Molecular FormulaC16H20ClN3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS=C1NC2=CC=C(Cl)C3=C2N1CC(N(CC=C(C)C)C3)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BNM-III-170
BNM-III-170 is a small-molecule CD4-mimetic compound that enhances vaccine efficacy against HIV-1 challenge in vivo.
-
GSK-2838232
GSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.
-
Dolutegravir sodium
Dolutegravir sodium (GSK-1349572A) is a potent, next-generation HIV integrase (IN) inhibitor, inhibits HIV-1 integrase-catalyzed strand transfer with IC50 of 2.7 nM.
